DISCOUNT-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 01:32:08 2024-06-14 pm EDT | ||
| 0.016 EUR | 0.00% |
|
| Current month | -15.79% | ||
| 1 month | -46.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.016 | 0.00% |
| 24-06-13 | 0.016 | -5.88% |
| 24-06-12 | 0.017 | 0.00% |
| 24-06-11 | 0.017 | 0.00% |
| 24-06-10 | 0.017 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 01:32 pm EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC40AG |
| ISIN | DE000HC40AG9 |
| Date issued | 2023-02-10 |
| Strike | 245 $ |
| Maturity | 2024-06-19 (3 Days) |
| Parity | 10 : 1 |
| Emission price | 1 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.33 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
